NewLeaf Symbiotics, Inc. Company Profile
NewLeaf Symbiotics is a development stage company based in the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis, MO. Formerly known as TrophoMax LLC, NewLeaf is commercializing Pink Pigmented Facultative Methylotrophs (PPFMs) for broad applications to the agriculture and horticulture industries. PPFMs are microorganisms that supply several essential nutrients that all plants need to grow. When PPFMs are applied to plants in a prescribed manner, the plants have been shown to grow faster and stronger, and to generate higher yields. Utilizing symbiotic microorganisms such as PPFMs to enhance plant growth and health can reduce the need for synthetic chemicals and other treatments, resulting in more profitable and sustainable farming.
A Series B funding round has brought in $17 million for NewLeaf Symbiotics, a St. -More-
Drugs and Medications
Functional foods are health promoters and their use is associated with reduced risk of chronic degenerative and non-transmissible diseases. Examples are symbiotic. The association of one (or more) pro...
Aim # 1: Determine the effect of two probiotic preparations (AKSB and Oxadrop) on urinary oxalate excretion in two well-defined groups of patients with enteric hyperoxaluria. Our hypothes...
NewLeaf Symbiotics is a development stage company based in the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis, MO. Formerly known ...
More Information about "NewLeaf Symbiotics, Inc." on BioPortfolio
We have published hundreds of NewLeaf Symbiotics, Inc. news stories on BioPortfolio along with dozens of NewLeaf Symbiotics, Inc. Clinical Trials and PubMed Articles about NewLeaf Symbiotics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NewLeaf Symbiotics, Inc. Companies in our database. You can also find out about relevant NewLeaf Symbiotics, Inc. Drugs and Medications on this site too.